You are here
INTEGRATED LABORATORY SYSTEMS, LLC
https://www.ils-inc.com
UEI: RWSSJRJLCDM4
# of Employees: 79
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Mutational profiling in human cells as an in vitro alternative to in vivo mutagenicity assessments
Amount: $249,903.00Project Summary A significant shift in the safety assessment of new drug candidates and environmental chemicals that can revolutionize the practice of regulatory toxicology is ongoing. This shift incl ...
SBIRPhase I2021Department of Health and Human Services National Institutes of Health -
CometChip: Development of a high throughput DNA damage assay in hepatocytes
Amount: $2,349,785.00An estimated 10,000 animals are used in toxicology safety assessments to meet all regulatory requirements with testing spanning 5 to 10 yrs and exceeding $10 million dollars. There is a critical need ...
SBIRPhase II2018Department of Health and Human Services National Institutes of Health -
Assay Development for Measuring Chemical Effects on the Epigenome in Stem Cells
Amount: $1,493,939.00DESCRIPTION provided by applicant This proposed project is in response to the need for more extensive toxicological evaluation of environmental chemicals and for better predictive models to assess ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
CometChip: Development of a high throughput DNA damage assay in hepatocytes
Amount: $1,400,732.00DESCRIPTION provided by applicant Thousands of new industrial chemicals are produced each year Knowledge about the potential carcinogenicity of these compounds is therefore critical to public heal ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
CometChip: Development of a high throughput DNA damage assay in hepatocytes
Amount: $224,969.00DESCRIPTION (provided by applicant): Thousands of new industrial chemicals are produced each year. Knowledge about the potential carcinogenicity of these compounds is therefore critical to public heal ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Integration of Genomic Biomarkers with the devTOX Human Embryonic Stem Cells Scre
Amount: $1,076,310.00DESCRIPTION provided by applicant In utero exposure to environmental chemicals or drugs accounts for approximately of all birth defects and can have an impact in adult life by disrupting the epi ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Endothelial Progenitor Cells for Assessing Toxicological Response Variability in
Amount: $224,313.00PROJECT SUMARY/ABSTRACT This proposed project is in response to the need for more extensive toxicological evaluation of environmental chemicals and for predictive models to assess associated risks of ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
SBIR PHASE I TOPIC 318: CYP1B1*3 GENOTYPE AND IMPACT ON DOCETAXEL MOA; HHSN261201
Amount: $299,359.00Not Available
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
Integration of Genomic Biomarkers with the devTOX Human Embryonic Stem Cells Scre
Amount: $149,936.00DESCRIPTION (provided by applicant): Current assays employed to assess the potential of drugs and environmental agents for their potential to cause birth defects involve the use of animal models. Not ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
VALIDATION OF A HUMAN CD34+ STEM CELL TOXICITY BIOASSAY
Amount: $144,428.00DESCRIPTION (provided by applicant): This SBIR application is submitted in response to the objectives of the NIEHS Predictive Test Systems for Safety Evaluation Program by developing, standardizing, ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health